<

 
Data updated 2025-07-16 00:05:01
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date13730652.8 (espacenet)  (Federated)  (European Patent Register), 20130509
Patent/reg. no. and dateDK/EP 2861579, 20180221
Publication date20150422
Priority no. and dateUS 201261647174 P, 20120515, US 201361790967 P, 20130315
EP pub. no. and date EP 2861579 20150422
Effective date
Applicant/ownerNovartis AG, Lichtstrasse 35
4056 Basel, CH
Applicant ref. no.156894/BT/GP
InventorDODD, Stephanie Kay, Novartis Institutes for BioMedical Research, Inc.,
250 Massachusetts Avenue,
Cambridge, Massachusetts 02139, US,
FURET, Pascal, Novartis Pharma AG,
Werk Klybeck Postfach,
4002 Basel, CH,
GROTZFELD, Robert Martin, Novartis Pharma AG,
Forum 1 Novartis Campus,
4056 Basel, CH,
JONES, Darryl Brynley, Novartis Pharma AG,
Forum 1 Novartis Campus,
4056 Basel, CH,
MANLEY, Paul, Novartis Pharma AG,
Werk Klybeck Postfach,
4002 Basel, CH,
MARZINZIK, Andreas, Novartis Pharma AG,
Werk Klybeck Postfach,
4002 Basel, CH,
PELLE, Xavier Francois Andre, Novartis Pharma AG,
Forum 1 Novartis Campus,
4056 Basel, CH,
SALEM, Bahaa, Novartis Pharma AG,
Werk Klybeck Postfach,
4002 Basel, CH,
SCHOEPFER, Joseph, Novartis Pharma AG,
Werk Klybeck Postfach,
4002 Basel, CH,
JAHNKE, Wolfgang, Novartis Pharma AG,
Postfach,
4002 Basel, CH
RepresentativeBudde Schou A/S, Dronningens Tværgade 30, 1302 København K
Opponent
IPC ClassA61K 31/4439 (2006.01) , A61P 35/00 (2006.01) , C07D 213/82 (2006.01) , C07D 401/04 (2006.01) , C07D 401/14 (2006.01) , C07D 403/10 (2006.01) 
TitleBenzamidderivater til at hæmme aktiviteten af ABL1, ABL2 og BCR-ABL1
Int. application no.IB2013053768
Int. publication no.WO2013171639
Related patent (certificate)CA 2022 00046
StatusRettet DK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact